- Reaction score
- 2,163
Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia - PMC
Dutasteride, a dual inhibitor of both type I and II 5α-reductases, is used to treat male pattern hair loss (MPHL). However, patient response to dutasteride varies in each individual, the cause of which is yet to be identified. To identify genetic ...
